Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-05-18

FDA Approved: LOKELMA — Original Application (AstraZeneca Pharmaceuticals LP)

View source ↗

Summary

FDA approved LOKELMA (sodium zirconium cyclosilicate) through its original NDA for the treatment of hyperkalemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lokelma (sodium zirconium cyclosilicate)

Snippet

ORIG AP for LOKELMA (SODIUM ZIRCONIUM CYCLOSILICATE)